Page last updated: 2024-08-24

halofuginone and Carcinoma, Lewis Lung

halofuginone has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Gong, L; Hou, H; Ji, K; Liu, N; Liu, W; Wang, P; Wang, Y; Zhao, L	1

Other Studies

1 other study(ies) available for halofuginone and Carcinoma, Lewis Lung

Article	Year
Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer. Oncotarget, 2016, Nov-01, Volume: 7, Issue:44 Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Lewis Lung; Cell Movement; Dioxoles; Epithelial-Mesenchymal Transition; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Piperidines; Quinazolinones; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays	2016

Article

Year

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.

Oncotarget, 2016, Nov-01, Volume: 7, Issue:44

Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Lewis Lung; Cell Movement; Dioxoles; Epithelial-Mesenchymal Transition; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Piperidines; Quinazolinones; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2016